Ulta Lab Tests

Search For Lab Tests Here

  • Page
  • 1
  • of
  • 2
  • Total Rows
  • 32
Name Matches

The Preventive Health & Cancer Screening Support - Comprehensive Male Lab Panel includes 22 tests and 125 biomarkers to support physician-guided review of preventive wellness and selected cancer marker support labs for men. It includes CBC, CMP, FIT/InSure®, PSA free and total, AFP/AFP-L3, CEA, CA 19-9, hepatitis, liver, kidney, thyroid, iron, inflammation, urinalysis, vitamin D, lipids, glucose, cystatin C, and immune protein labs.

Urine, Serum, Blood, Varied, Random
Phlebotomist
Also Known As: Preventive Cancer Marker Male Panel, Men’s Cancer Marker Lab Panel, Male Cancer Marker Blood Test, Men’s Preventive Health Panel, Male Preventive Cancer Marker Panel, Men’s Tumor Marker Panel, Comprehensive Male Cancer Marker Panel
Panel Contains Test: CBC (includes Differential and Platelets) Comprehensive Metabolic Panel (CMP) Urinalysis (UA), Complete hs-CRP Ferritin Iron and Total Iron Binding Capacity (TIBC) Fecal Globin by Immunochemistry (InSure®) PSA, Free and Total Hemoglobin A1c (HgbA1C) Lipid Panel TSH QuestAssureD™ 25-Hydroxyvitamin D (D2, D3), LC/MS/MS Hepatitis Panel, General Albumin, Random Urine with Creatinine CEA Alpha-Fetoprotein (AFP) and AFP-L3 Lactate Dehydrogenase (LD) Gamma Glutamyl Transferase (GGT) Immunoglobulins Panel, Serum CA 19-9 CYSTATIN C WITH eGFR Bilirubin, Fractionated
Add to  

The Alpha Fetoprotein (AFP) Tumor Marker Test measures AFP levels in blood to help detect and monitor cancers such as liver cancer, testicular cancer, and certain ovarian tumors. Elevated AFP may also be seen with liver disease, cirrhosis, or hepatitis. Doctors order this test for patients at risk of or being treated for cancer. Results provide essential insight for diagnosis, monitoring treatment response, and tracking cancer recurrence or progression.

Blood
Blood Draw
Also Known As: Alpha-Fetoprotein Test, AFP Tumor Marker Test
Add to  

The Alpha-Fetoprotein (AFP) and AFP-L3 Test measures total AFP and the AFP-L3 fraction, which is more specific for liver cancer risk. Elevated AFP may indicate liver disease, germ cell tumors, or hepatitis, while AFP-L3 is strongly associated with hepatocellular carcinoma (HCC). Doctors order this test to assess liver function, screen high-risk patients, and monitor cancer treatment. Results provide critical insight into liver health and cancer detection.

Blood
Blood Draw
Also Known As: AFP Test, Total AFP Test, Alpha-Fetoprotein Tumor Markers, Alpha-Fetoprotein Test
Add to  

The Maternal AFP Test evaluates alpha-fetoprotein levels during pregnancy to assess fetal development and identify possible abnormalities. Variations in AFP may signal neural tube defects, abdominal wall issues, or genetic conditions such as trisomy 21. As part of prenatal screening, this test provides insight into maternal health and supports early evaluation of fetal growth and pregnancy outcomes.

Blood
Blood Draw
Also Known As: Maternal Alpha Fetoprotein Test
Add to  
 The Cancer Screening - Men panel is a comprehensive diagnostic tool designed to detect early signs of various cancers in men. This panel includes a series of tests that measure specific biomarkers associated with different types of cancer. By assessing these biomarkers, healthcare providers can identify the presence of cancer at an early stage, when treatment is often more effective. This panel is crucial for men who are at higher risk of developing cancer due to factors such as age, family history, or lifestyle.
Blood
Blood Draw
Panel Contains Test: CA 125 Alpha-Fetoprotein (AFP) and AFP-L3 CEA CA 19-9 PSA Total
Add to  
Blood
Blood Draw
Panel Contains Test: Alpha-Fetoprotein (AFP) and AFP-L3 PSA, Free and Total CA 19-9
Add to  
 The CA-1 Cancer Screening - Women panel is specifically designed as an initial screening tool for the early detection of various cancers that commonly affect women. This panel combines several tumor markers and protein measurements, each carefully selected for their relevance in detecting specific cancer types. The panel is an important resource for those who are at increased risk of cancer, either due to family history, genetic predisposition, or other risk factors. By measuring specific biomarkers, this panel helps in identifying cancer at an early stage, where treatment can be more effective and less invasive.
Blood
Blood Draw
Panel Contains Test: Alpha-Fetoprotein (AFP) and AFP-L3 CA 125 CA 27.29 CA 19-9 CA 15-3
Add to  
The Cancer Screening - Women Panel is a comprehensive set of blood tests designed to detect various cancer markers in women. This panel assesses levels of specific proteins that can be elevated in the presence of certain types of cancer. By measuring these markers, healthcare providers can gain valuable insights into a patient's risk of having cancer, monitor the progression of the disease, and evaluate the effectiveness of treatment.
Blood
Blood Draw
Panel Contains Test: Alpha-Fetoprotein (AFP) and AFP-L3 CA 125 CEA CA 19-9 CA 15-3
Add to  
Blood
Blood Draw
Panel Contains Test: Amylase Thyroglobulin Antibodies (TgAb) PSA, Free and Total Alpha-Fetoprotein (AFP) and AFP-L3 CEA Lactate Dehydrogenase (LD) CBC (includes Differential and Platelets) CA 19-9
Add to  
Blood, Varied
Blood Draw, Phlebotomist
Panel Contains Test: PSA, Free and Total CA 125 Amylase Fecal Globin by Immunochemistry (InSure®) Comprehensive Metabolic Panel (CMP) Alpha-Fetoprotein (AFP) and AFP-L3 CEA CA 19-9
Add to  
Blood, Varied
Blood Draw, Phlebotomist
Panel Contains Test: Comprehensive Metabolic Panel (CMP) Fecal Globin by Immunochemistry (InSure®) Alpha-Fetoprotein (AFP) and AFP-L3 CA 125 Amylase CEA CA 15-3 CA 19-9
Add to  
 The CA-2 Cancer Screening - Women panel is a specialized diagnostic tool designed for the early detection and ongoing monitoring of various cancers specifically in women. It expands upon basic cancer screening by including additional markers that provide a wider range of detection and insight into different types of cancers. This panel is particularly valuable for women who are at increased risk due to genetic predispositions, family history, or environmental factors. It helps in the early identification of cancer, potentially improving the effectiveness of treatments and increasing the chances of successful outcomes.
Blood
Blood Draw
Panel Contains Test: Thyroglobulin Antibodies (TgAb) CA 27.29 Amylase CA 125 Alpha-Fetoprotein (AFP) and AFP-L3 CEA CBC (includes Differential and Platelets) CA 15-3 Lactate Dehydrogenase (LD) CA 19-9
Add to  
The LH-2 Liver Health panel is a comprehensive suite of tests designed to evaluate liver function, identify liver damage, and screen for specific liver disorders. This panel includes Quantitative Alpha-1-Antitrypsin, Alpha-Fetoprotein and AFP-L3, Fractionated Bilirubin (Direct, Indirect, and Total), Ceruloplasmin, Comprehensive Metabolic Panel, Gamma Glutamyl Transferase, Iron and Total Iron Binding Capacity, Lactate Dehydrogenase, and Prothrombin Time with INR. Each of these tests offers valuable insights into liver health, potential liver disease, and the liver's capacity to perform its vital functions.
Blood
Blood Draw
Panel Contains Test: Alpha-1-Antitrypsin, Quantitative Ceruloplasmin Alpha-Fetoprotein (AFP) and AFP-L3 Comprehensive Metabolic Panel (CMP) Iron and Total Iron Binding Capacity (TIBC) Prothrombin Time (PT) with INR Lactate Dehydrogenase (LD) Gamma Glutamyl Transferase (GGT) Bilirubin, Fractionated
Add to  
Blood
Blood Draw, Phlebotomist
Panel Contains Test: Comprehensive Metabolic Panel (CMP) Alpha-Fetoprotein (AFP) and AFP-L3 CARDIO IQ(R) INSULIN RESISTANCE PANEL WITH SCORE Lipid Panel Prothrombin Time (PT) with INR Hemoglobin A1c (HgbA1C) Ferritin C-Reactive Protein (CRP) Gamma Glutamyl Transferase (GGT) CBC (includes Differential and Platelets)
Add to  
Blood, Varied
Blood Draw, Phlebotomist
Panel Contains Test: Fecal Globin by Immunochemistry (InSure®) Alpha-Fetoprotein (AFP) and AFP-L3 PSA, Free and Total Thyroglobulin Antibodies (TgAb) Amylase hCG, Total, Quantitative CEA Gastrin CA 19-9 CBC (includes Differential and Platelets) Lactate Dehydrogenase (LD)
Add to  
 The CA-3 Cancer Screening - Women panel is an extensive diagnostic tool designed for an in-depth analysis of various cancer-related markers, specifically tailored for women. This advanced screening panel integrates additional markers to enhance the detection and monitoring capabilities for a broad spectrum of cancers. It is instrumental in providing a comprehensive overview of a woman's cancer risk profile, facilitating early intervention, and guiding effective treatment strategies.
Blood, Varied
Blood Draw, Phlebotomist
Panel Contains Test: Alpha-Fetoprotein (AFP) and AFP-L3 Fecal Globin by Immunochemistry (InSure®) CA 125 Amylase CA 27.29 Thyroglobulin Antibodies (TgAb) CEA hCG, Total, Quantitative Gastrin CA 19-9 Lactate Dehydrogenase (LD) CA 15-3 CBC (includes Differential and Platelets)
Add to  
Blood
Blood Draw, Phlebotomist
Panel Contains Test: Comprehensive Metabolic Panel (CMP) Alpha-Fetoprotein (AFP) and AFP-L3 DCP (Des-Gamma-Carboxy-Prothrombin) Alpha-1-Antitrypsin, Quantitative Ceruloplasmin Copper Hepatitis C AB with reflex to HCV RNA, QN, PCR Iron and Total Iron Binding Capacity (TIBC) Prothrombin Time (PT) with INR Hepatitis B Surface Antigen with Reflex Confirmation Hepatitis A Antibody, Total Lactate Dehydrogenase (LD) Gamma Glutamyl Transferase (GGT)
Add to  
The LH-3 Liver Health panel is an extensive diagnostic tool designed to provide a comprehensive assessment of liver health. This panel includes a wide range of tests that evaluate liver function, screen for liver infections, and assess liver damage. It comprises Quantitative Alpha-1-Antitrypsin, Alpha-Fetoprotein and AFP-L3, Fractionated Bilirubin, Ceruloplasmin, Comprehensive Metabolic Panel, Copper, Gamma Glutamyl Transferase, Hepatitis A, B, and C antibodies and antigens, Iron and Total Iron Binding Capacity, Lactate Dehydrogenase, and Prothrombin Time with INR.
Blood
Blood Draw, Phlebotomist
Panel Contains Test: Comprehensive Metabolic Panel (CMP) Alpha-Fetoprotein (AFP) and AFP-L3 Copper Ceruloplasmin Alpha-1-Antitrypsin, Quantitative Prothrombin Time (PT) with INR Iron and Total Iron Binding Capacity (TIBC) Hepatitis C AB with reflex to HCV RNA, QN, PCR Bilirubin, Fractionated Gamma Glutamyl Transferase (GGT) Lactate Dehydrogenase (LD) Hepatitis A Antibody, Total Hepatitis B Surface Antigen with Reflex Confirmation Hepatitis B Core Antibody (IgM)
Add to  
Blood, Varied
Blood Draw, Phlebotomist
Panel Contains Test: Amylase Calcitonin Thyroglobulin Antibodies (TgAb) DCP (Des-Gamma-Carboxy-Prothrombin) PSA, Free and Total Alpha-Fetoprotein (AFP) and AFP-L3 Fecal Globin by Immunochemistry (InSure®) CEA hCG, Total, Quantitative Lactate Dehydrogenase (LD) CBC (includes Differential and Platelets) CA 19-9 Gastrin
Add to  
 The CA-4 Cancer Screening - Women panel is the most comprehensive diagnostic tool available for assessing cancer risk and monitoring the health of women potentially at high risk for various cancers. It encompasses an extensive range of biomarkers, each specifically chosen to detect early signs of cancer and monitor treatment progress or recurrence. This panel is essential for women with a significant family history of cancer, known genetic predispositions, or those who have had previous cancer diagnoses and need close surveillance.
Blood, Varied
Blood Draw, Phlebotomist
Panel Contains Test: DCP (Des-Gamma-Carboxy-Prothrombin) CA 27.29 Amylase CA 125 Thyroglobulin Antibodies (TgAb) Calcitonin Fecal Globin by Immunochemistry (InSure®) Alpha-Fetoprotein (AFP) and AFP-L3 hCG, Total, Quantitative CEA CBC (includes Differential and Platelets) CA 15-3 Lactate Dehydrogenase (LD) CA 19-9 Gastrin
Add to  
The LH-4 Liver Health panel is the most comprehensive suite of tests tailored to provide an in-depth evaluation of liver health, function, and the presence of liver diseases, including liver cancer and viral hepatitis. It encompasses a broad spectrum of markers, from liver enzymes and proteins to specific tests for genetic conditions, liver cancer markers, and comprehensive screening for hepatitis infections.
Blood
Blood Draw, Phlebotomist
Panel Contains Test: DCP (Des-Gamma-Carboxy-Prothrombin) Alpha-1-Antitrypsin, Quantitative Ceruloplasmin Copper Hepatitis C Viral RNA, Quantitative, Real-Time PCR Alpha-Fetoprotein (AFP) and AFP-L3 Comprehensive Metabolic Panel (CMP) Hepatitis C AB with reflex to HCV RNA, QN, PCR Iron and Total Iron Binding Capacity (TIBC) Prothrombin Time (PT) with INR Hepatitis B Core Antibody (IgM) Hepatitis B Surface Antigen with Reflex Confirmation Hepatitis A Antibody, Total Lactate Dehydrogenase (LD) Gamma Glutamyl Transferase (GGT) Bilirubin, Fractionated
Add to  
Blood, Varied
Blood Draw, Phlebotomist
Panel Contains Test: DCP (Des-Gamma-Carboxy-Prothrombin) Calcitonin Thyroglobulin Antibodies (TgAb) CA 125 Amylase CA 27.29 PSA, Free and Total Fecal Globin by Immunochemistry (InSure®) Alpha-Fetoprotein (AFP) and AFP-L3 CHROMOGRANIN A, LC/MS/MS Protein Electrophoresis, Serum hCG, Total, Quantitative CEA CBC (includes Differential and Platelets) Lactate Dehydrogenase (LD) CA 15-3 CA 19-9 Gastrin
Add to  
Blood
Blood Draw, Phlebotomist
Panel Contains Test: Comprehensive Metabolic Panel (CMP) Lipid Panel with Ratios Alpha-Fetoprotein (AFP) and AFP-L3 Mitochondrial Antibody with Reflex to Titer Alpha-1-Antitrypsin, Quantitative Ceruloplasmin Zinc Protoporphyrin (ZPP) Iron and Total Iron Binding Capacity (TIBC) Transferrin Prothrombin Time (PT) with INR Hepatitis Panel, General Bilirubin, Fractionated ANCA Screen with Reflex to ANCA Titer Gamma Glutamyl Transferase (GGT) Prealbumin Ferritin C-Reactive Protein (CRP) CBC (includes Differential and Platelets) Lactate Dehydrogenase (LD)
Add to  

The Preventive Health & Cancer Marker Lab Panel - Advanced Male includes 19 tests and 114 biomarkers to support physician-guided review of preventive wellness and selected cancer marker patterns. It includes CBC, CMP, FIT/InSure®, PSA free and total, AFP/AFP-L3, CEA, CA 19-9, liver, kidney, thyroid, iron, inflammation, urinalysis, vitamin D, lipids, glucose, cystatin C, urine albumin, GGT, bilirubin, ferritin, and iron/TIBC.

Urine, Serum, Blood, Varied, Random
Phlebotomist
Also Known As:

Essential Cancer Marker Male Panel, Men’s Essential Cancer Marker Panel, Male Preventive Health Panel, Men’s PSA and FIT Panel, Essential Male Cancer Marker Blood Test, Men’s Preventive Cancer Marker Panel

Panel Contains Test: CBC (includes Differential and Platelets) Comprehensive Metabolic Panel (CMP) Urinalysis (UA), Complete hs-CRP Ferritin Iron and Total Iron Binding Capacity (TIBC) Fecal Globin by Immunochemistry (InSure®) PSA, Free and Total Hemoglobin A1c (HgbA1C) Lipid Panel TSH QuestAssureD™ 25-Hydroxyvitamin D (D2, D3), LC/MS/MS Albumin, Random Urine with Creatinine Alpha-Fetoprotein (AFP) and AFP-L3 Bilirubin, Fractionated CA 19-9 CEA CYSTATIN C WITH eGFR Gamma Glutamyl Transferase (GGT)
Add to  
Blood, Varied
Blood Draw, Phlebotomist
Panel Contains Test: Copper Comprehensive Metabolic Panel (CMP) Alpha 1 Antitrypsin,Feces Random Lipid Panel with Ratios Alpha-Fetoprotein (AFP) and AFP-L3 Alpha-1-Antitrypsin, Quantitative Mitochondrial Antibody with Reflex to Titer Ceruloplasmin Zinc Protoporphyrin (ZPP) Iron and Total Iron Binding Capacity (TIBC) Protein, Total and Protein Electrophoresis, with Scan Transferrin Prothrombin Time (PT) with INR Hepatitis Panel, General ANCA Screen with Reflex to ANCA Titer Bilirubin, Fractionated Gamma Glutamyl Transferase (GGT) Prealbumin Ferritin C-Reactive Protein (CRP) CBC (includes Differential and Platelets) Lactate Dehydrogenase (LD)
Add to